CYCLOPHOSPHAMIDE AND MS

CYCLOPHOSPHAMIDE AND MS

Show other versions (1)

Bibliographic Details
Main Authors:	Noseworthy, J, Ebers, G, Roberts, R
Format:	Journal article
Published:	1994

Similar Items

Cyclophosphamide and MS.
by: Noseworthy, J, et al.
Published: (1994)

PLASMA-EXCHANGE FOR MS
by: Noseworthy, J, et al.
Published: (1990)

Plasma exchange for MS.
by: Noseworthy, J, et al.
Published: (1990)

MS REFERENDUM - REPLY
by: Noseworthy, J, et al.
Published: (1990)

Measuring disability progression in MS
by: Ebers, G, et al.
Published: (2005)

Erratum: Plasma exchange for MS (Neurology (1990) 40 (864-866))
by: Noseworthy, J, et al.
Published: (1990)

MULTIPLE-SCLEROSIS (MS) PRESENTING IN PATIENTS OVER 50 YEARS OF AGE
by: Noseworthy, J, et al.
Published: (1981)

Disability as an outcome in MS clinical trials.
by: Ebers, G, et al.
Published: (2008)

The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis. The Canadian Cooperative Multiple Sclerosis Study Group.
by: Noseworthy, J
Published: (1991)

Interrater variability with the Expanded Disability Status Scale (EDSS) and Functional Systems (FS) in a multiple sclerosis clinical trial. The Canadian Cooperation MS Study Group.
by: Noseworthy, J, et al.
Published: (1990)

Development and validation of a UPLC-MS/MS method with volumetric absorptive microsampling to quantitate cyclophosphamide and 4-hydroxycyclophosphamide
by: Yahdiana Harahap, et al.
Published: (2022-08-01)

MS and autoimmune disorders.
by: Ebers, G
Published: (2009)

Oligoclonal banding in MS.
by: Ebers, G
Published: (1984)

Primary biliary cirrhosis and multiple sclerosis.
by: Noseworthy, J, et al.
Published: (1989)

A twin consensus in MS.
by: Ebers, G
Published: (2005)

MS - EVIDENCE FOR AN ENVIRONMENTAL-EFFECT
by: Cripps, J, et al.
Published: (1982)

Azathioprine, cyclophosphamide and chlorambucil.
by: Luqmani, R, et al.
Published: (1990)

Cyclophosphamide and systemic vasculitis.
by: Luqmani, R, et al.
Published: (1993)

Natural history of MS.
by: Ebers, G, et al.
Published: (2008)

Familial studies in MS: genes and environment
by: Ebers, G
Published: (2009)

The relationship of clinically isolated syndromes and MS
by: Ebers, G
Published: (2009)

Therapeutic trials in multiple sclerosis.
by: Noseworthy, J, et al.
Published: (1984)

OPTIC NEURITIS (ON) IN FAMILIAL MS
by: Ebers, G, et al.
Published: (1980)

Lipidomics of cyclophosphamide 4‐hydroxylation in patients receiving post‐transplant cyclophosphamide
by: Sandi L. Navarro, et al.
Published: (2022-11-01)

Epidemiology of MS: Results from the London Ontario database
by: Ebers, G
Published: (2007)

CYCLOPHOSPHAMIDE, AZATHIOPRINE, AND MALIGNANCY
by: Kinlen, L
Published: (1977)

ACCEPTANCE OF PLACEBO-CONTROL TRIAL DESIGN BY PROGRESSIVE MULTIPLE-SCLEROSIS PATIENTS
by: Noseworthy, J, et al.
Published: (1989)

Neuroimaging in multiple sclerosis.
by: Noseworthy, J, et al.
Published: (1984)

Acceptance of placebo-control trial design by progressive multiple sclerosis patients. The Canadian Cooperative Multiple Sclerosis Study Group.
by: Noseworthy, J, et al.
Published: (1989)

THE GEOGRAPHY OF MS REFLECTS GENETIC SUSCEPTIBILITY
by: Ebers, G, et al.
Published: (1986)

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial.
by: Noseworthy, J, et al.
Published: (1994)

The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. 1994 [classical article]
by: Noseworthy, J, et al.
Published: (2001)

Environmental factors in multiple sclerosis: Review of an MS forum workshop
by: Ebers, G
Published: (2000)

Optimisation of cyclophosphamide therapy in systemic vasculitis.
by: Richmond, R, et al.
Published: (1998)

MS MORTALITY - REPLY
by: Sadovnick, A, et al.
Published: (1992)

ANTI-IDIOTYPIC SERA IN THE STUDY OF MS CSF BANDS - FURTHER-STUDIES
by: Ebers, G
Published: (1981)

Optic neuritis in familial MS.
by: Ebers, G, et al.
Published: (1981)

Multifocal CT enhancement in MS.
by: Ebers, G, et al.
Published: (1984)

MARKERS AND PROGNOSIS IN MULTIPLE-SCLEROSIS
by: Noseworthy, J, et al.
Published: (1983)

Cyclophosphamide: As bad as its reputation?
by: Diana Dan, et al.
Published: (2014-10-01)